|
|
||||||||
Original Articles |
Leakage of plasma proteins into the alveolar space may inhibit surfactant function. We compared the surface properties and the sensitivity to inhibitory proteins of different organic solvent surfactant extracts and a synthetic surfactant. Experiments were performed in the pulsating bubble surfactometer, with surfactant concentrations ranging between 0.1 and 2 mg.ml-1. Inhibition profiles towards fibrinogen, albumin and haemoglobin were obtained from calf lung surfactant extracts (CLSE), Alveofact, Curosurf and Survanta (all used in clinical, replacement studies in respiratory distress syndrome (RDS) and of an apoprotein-based synthetic phospholipid mixture (PLM-C/B; DPPC:PG:PA = 68.5:22.5:9, supplemented with 2% wt/wt non-palmitoylated human recombinant SP-C and 1% t/wt natural bovine SP-B). In the absence of inhibitory proteins, all surfactants exhibited dose-dependent rapid adsorption (rank order of relative efficacy PLM-C/B = CLSE > Alveofact > Curosurf > Survanta). Minimal surface tension was reduced to near zero values under dynamic compression (rank order PLM-C/B > CLSE > Alveofact = Curosurf) and to approximately 4 mN.m-1 (Survanta). Curosurf and Survanta were dose-dependently inhibited by fibrinogen > haemoglobin > albumin, with far-reaching loss of surface activity at protein-surfactant ratios above 1:1. In contrast, CLSE and Alveofact were only moderately inhibited by fibrinogen, and were not affected by haemoglobin and albumin, up to protein-surfactant ratios of 2:1. PLM-C/B exhibited resistance to fibrinogen, intermediate sensitivity to albumin, and was severely inhibited by haemoglobin. We conclude that various natural surfactant extracts and an apoprotein-based synthetic surfactant mixture markedly differ in their sensitivity to inhibitory plasma proteins.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
Y. Y. Zuo, S. M. Tadayyon, E. Keating, L. Zhao, R. A. W. Veldhuizen, N. O. Petersen, M. W. Amrein, and F. Possmayer Atomic Force Microscopy Studies of Functional and Dysfunctional Pulmonary Surfactant Films, II: Albumin-Inhibited Pulmonary Surfactant Films and the Effect of SP-A Biophys. J., September 15, 2008; 95(6): 2779 - 2791. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. von Bismarck, C.-F. Garcia Wistadt, K. Klemm, S. Winoto-Morbach, U. Uhlig, S. Schutze, D. Adam, B. Lachmann, S. Uhlig, and M. F. Krause Improved Pulmonary Function by Acid Sphingomyelinase Inhibition in a Newborn Piglet Lavage Model Am. J. Respir. Crit. Care Med., June 1, 2008; 177(11): 1233 - 1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Maruscak, D. W. Vockeroth, B. Girardi, T. Sheikh, F. Possmayer, J. F. Lewis, and R. A. W. Veldhuizen Alterations to surfactant precede physiological deterioration during high tidal volume ventilation Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L974 - L983. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Bakshi, L. Zhao, R. Smith, F. Possmayer, and N. O. Petersen Metal Nanoparticle Pollutants Interfere with Pulmonary Surfactant Function In Vitro Biophys. J., February 1, 2008; 94(3): 855 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, Y. Chang, A. L. Schwan, and R. H. Notter Activity and Inhibition Resistance of a Phospholipase-Resistant Synthetic Surfactant in Rat Lungs Am. J. Respir. Cell Mol. Biol., October 1, 2007; 37(4): 387 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Braun, P. C. Stenger, H. E. Warriner, J. A. Zasadzinski, K. W. Lu, and H. W. Taeusch A Freeze-Fracture Transmission Electron Microscopy and Small Angle X-Ray Diffraction Study of the Effects of Albumin, Serum, and Polymers on Clinical Lung Surfactant Microstructure Biophys. J., July 1, 2007; 93(1): 123 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Allen, T. Leclair, M. Cloutier, J. Thompson-Figueroa, and J. H. T. Bates The response to recruitment worsens with progression of lung injury and fibrin accumulation in a mouse model of acid aspiration Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1580 - L1589. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Truog, P. L. Ballard, M. Norberg, S. Golombek, R. C. Savani, J. D. Merrill, L. A. Parton, A. Cnaan, X. Luan, R. A. Ballard, et al. Inflammatory Markers and Mediators in Tracheal Fluid of Premature Infants Treated With Inhaled Nitric Oxide Pediatrics, April 1, 2007; 119(4): 670 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Taeusch, J. B. de la Serna, J. Perez-Gil, C. Alonso, and J. A. Zasadzinski Inactivation of Pulmonary Surfactant Due to Serum-Inhibited Adsorption and Reversal by Hydrophilic Polymers: Experimental Biophys. J., September 1, 2005; 89(3): 1769 - 1779. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. R. Moya, J. Gadzinowski, E. Bancalari, V. Salinas, B. Kopelman, A. Bancalari, M. K. Kornacka, T. A. Merritt, R. Segal, C. J. Schaber, et al. A Multicenter, Randomized, Masked, Comparison Trial of Lucinactant, Colfosceril Palmitate, and Beractant for the Prevention of Respiratory Distress Syndrome Among Very Preterm Infants Pediatrics, April 1, 2005; 115(4): 1018 - 1029. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Hite, M. C. Seeds, D. L. Bowton, B. L. Grier, A. M. Safta, R. Balkrishnan, B. M. Waite, and D. A. Bass Surfactant phospholipid changes after antigen challenge: a role for phosphatidylglycerol in dysfunction Am J Physiol Lung Cell Mol Physiol, April 1, 2005; 288(4): L610 - L617. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rudiger, A. Tolle, W. Meier, and B. Rustow Naturally derived commercial surfactants differ in composition of surfactant lipids and in surface viscosity Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L379 - L383. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Willson, N. J. Thomas, B. P. Markovitz, L. A. Bauman, J. V. DiCarlo, S. Pon, B. R. Jacobs, L. S. Jefferson, M. R. Conaway, E. A. Egan, et al. Effect of Exogenous Surfactant (Calfactant) in Pediatric Acute Lung Injury: A Randomized Controlled Trial JAMA, January 26, 2005; 293(4): 470 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gunther, M. Balser, R. Schmidt, P. Markart, A. Olk, J. Borgermann, F. H. Splittgerber, W. Seeger, and I. Friedrich Surfactant abnormalities after single lung transplantation in dogs: Impact of bronchoscopic surfactant administration J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 344 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Allen and J. H. T. Bates Dynamic mechanical consequences of deep inflation in mice depend on type and degree of lung injury J Appl Physiol, January 1, 2004; 96(1): 293 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kutschka, S. P. Sommer, J. M. Hohlfeld, G. Warnecke, M. Morancho, S. Fischer, A. Haverich, M. Struber, and the Hannover Thoracic Transplant Program In-situ topical cooling of lung grafts: early graft function and surfactant analysis in a porcine single lung transplant model Eur. J. Cardiothorac. Surg., September 1, 2003; 24(3): 411 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
Statement on the Care of the Child with Chronic Lung Disease of Infancy and Childhood Am. J. Respir. Crit. Care Med., August 1, 2003; 168(3): 356 - 396. [Full Text] [PDF] |
||||
![]() |
Z. Wang, J. E. Baatz, B. A. Holm, and R. H. Notter Content-dependent activity of lung surfactant protein B in mixtures with lipids Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L897 - L906. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bachofen, U. Gerber, and S. Schurch Effects of fixatives on function of pulmonary surfactant J Appl Physiol, September 1, 2002; 93(3): 911 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gunther, R. Schmidt, J. Harodt, T. Schmehl, D. Walmrath, C. Ruppert, F. Grimminger, and W. Seeger Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties Eur. Respir. J., May 1, 2002; 19(5): 797 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wu, M. Singer, F. Thouron, M. Alaoui-El-Azher, and L. Touqui Effect of surfactant on pulmonary expression of type IIA PLA2 in an animal model of acute lung injury Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L743 - L750. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. SCHMIDT, W. STEINHILBER, C. RUPPERT, C. DAUM, F. GRIMMINGER, W. SEEGER, and A. GUNTHER An ELISA Technique for Quantification of Surfactant Apoprotein (SP)-C in Bronchoalveolar Lavage Fluid Am. J. Respir. Crit. Care Med., February 15, 2002; 165(4): 470 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. CAMPBELL, K. BOSMA, A. BRACKENBURY, L. MCCAIG, L.-J. YAO, R. VELDHUIZEN, and J. LEWIS Polyethylene Glycol (PEG) Attenuates Exogenous Surfactant in Lung-injured Adult Rabbits Am. J. Respir. Crit. Care Med., February 15, 2002; 165(4): 475 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Gupta, J M Hernandez-Juviel, A J Waring, and F J Walther Function and inhibition sensitivity of the N-terminal segment of surfactant protein B (SP-B1-25) in preterm rabbits Thorax, November 1, 2001; 56(11): 871 - 876. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Schermuly, A. Gunther, M. Ermert, L. Ermert, H. A. Ghofrani, N. Weissmann, F. Grimminger, W. Seeger, and D. Walmrath Conebulization of surfactant and urokinase restores gas exchange in perfused lungs with alveolar fibrin formation Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L792 - L800. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. ALMAAS, B. ROBERTSON, B. LINDERHOLM, E. LUNDBERG, O. D. SAUGSTAD, and A. MOEN Reversal of Meconium Inhibition of Pulmonary Surfactant by Ferric Chloride, Copper Chloride, and Acetic Acid Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1789 - 1794. [Abstract] [Full Text] |
||||
![]() |
W. BERNHARD, J. MOTTAGHIAN, A. GEBERT, G. A. RAU, H. von der HARDT, and C. F. POETS Commercial versus Native Surfactants . Surface Activity, Molecular Components, and the Effect of Calcium Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1524 - 1533. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Rauprich, O. Moller, G. Walter, E. Herting, and B. Robertson Influence of Modified Natural or Synthetic Surfactant Preparations on Growth of Bacteria Causing Infections in the Neonatal Period Clin. Vaccine Immunol., September 1, 2000; 7(5): 817 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kattwinkel, B. T. Bloom, P. Delmore, C. Glick, D. Brown, S. Lopez, L. Willett, E. A. Egan, M. Conaway, and J. Patrie High-Versus Low-Threshold Surfactant Retreatment For Neonatal Respiratory Distress Syndrome Pediatrics, August 1, 2000; 106(2): 282 - 288. [Abstract] [Full Text] |
||||
![]() |
D. HÄFNER and P.-G. GERMANN Additive Effects of Phosphodiesterase-4 Inhibition on Effects of rSP-C Surfactant Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1495 - 1500. [Abstract] [Full Text] |
||||
![]() |
T. E. WISWELL, R. M. SMITH, L. B. KATZ, L. MASTROIANNI, D. Y. WONG, D. WILLMS, S. HEARD, M. WILSON, R. D. HITE, A. ANZUETO, et al. Bronchopulmonary Segmental Lavage with Surfaxin (KL4-Surfactant) for Acute Respiratory Distress Syndrome Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1188 - 1195. [Abstract] [Full Text] |
||||
![]() |
B. M. Elhalwagi, M. Zhang, M. Ikegami, H. S. Iwamoto, R. E. Morris, M. L. Miller, K. Dienger, and F. X. McCormack Normal Surfactant Pool Sizes and Inhibition-Resistant Surfactant from Mice That Overexpress Surfactant Protein A Am. J. Respir. Cell Mol. Biol., September 1, 1999; 21(3): 380 - 387. [Abstract] [Full Text] |
||||
![]() |
M. Griese, C. Wilnhammer, S. Jansen, and C. Rinker CARDIOPULMONARY BYPASS REDUCES PULMONARY SURFACTANT ACTIVITY IN INFANTS J. Thorac. Cardiovasc. Surg., August 1, 1999; 118(2): 237 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. HOHLFELD, K. AHLF, G. ENHORNING, K. BALKE, V. J. ERPENBECK, J. PETSCHALLIES, H. G. HOYMANN, H. FABEL, and N. KRUG Dysfunction of Pulmonary Surfactant in Asthmatics after Segmental Allergen Challenge Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1803 - 1809. [Abstract] [Full Text] |
||||
![]() |
H. W. TAEUSCH, K. W. LU, J. GOERKE, and J. A. CLEMENTS Nonionic Polymers Reverse Inactivation of Surfactant by Meconium and Other Substances Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1391 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. WANG and R. H. NOTTER Additivity of Protein and Nonprotein Inhibitors of Lung Surfactant Activity Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 28 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. HAFNER, P.-G. GERMANN, and D. HAUSCHKE Effects of rSP-C Surfactant on Oxygenation and Histology in a Rat-Lung-Lavage Model of Acute Lung Injury Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 270 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Y. Haddad, B. Nieves-Cruz, and S. Matalon Inhibition of surfactant function by copper-zinc superoxide dismutase (CuZn-SOD) J Appl Physiol, November 1, 1997; 83(5): 1545 - 1550. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. WALTHER, J. HERNANDEZ-JUVIEL, R. BRUNI, and A. J. WARING Spiking Survanta with Synthetic Surfactant Peptides Improves Oxygenation in Surfactant-deficient Rats Am. J. Respir. Crit. Care Med., September 1, 1997; 156(3): 855 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. SCHERMULY, T. SCHMEHL, A. GÜNTHER, F. GRIMMINGER, W. SEEGER, and D. WALMRATH Ultrasonic Nebulization for Efficient Delivery of Surfactant in a Model of Acute Lung Injury . Impact on Gas Exchange Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 445 - 453. [Abstract] [Full Text] |
||||
![]() |
B. T. Bloom, J. Kattwinkel, R. T. Hall, P. M. Delmore, E. A. Egan, J. R. Trout, M. H. Malloy, D. R. Brown, I. R. Holzman, C. H. Coghill, et al. Comparison of Infasurf (Calf Lung Surfactant Extract) to Survanta (Beractant) in the Treatment and Prevention of Respiratory Distress Syndrome Pediatrics, July 1, 1997; 100(1): 31 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Hudak, D. J. Martin, E. A. Egan, E. J. Matteson, J. Cummings, A. L. Jung, L. V. Kimberlin, R. L. Auten, A. A. Rosenberg, J. M. Asselin, et al. A Multicenter Randomized Masked Comparison Trial of Synthetic Surfactant Versus Calf Lung Surfactant Extract in the Prevention of Neonatal Respiratory Distress Syndrome Pediatrics, July 1, 1997; 100(1): 39 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hausen, R. Rohde, C. W. Hewitt, F. Schroeder, M. Beuke, R. Ramsamooj, H.-J. Schafers, Sponsor:, and H.-G. Borst EXOGENOUS SURFACTANT TREATMENT BEFORE AND AFTER SIXTEEN HOURS OF ISCHEMIA IN EXPERIMENTAL LUNG TRANSPLANTATION J. Thorac. Cardiovasc. Surg., June 1, 1997; 113(6): 1050 - 1058. [Abstract] [Full Text] |
||||
![]() |
J. H. van Blankenstein, C. J Slager, L. K. Soei, H Boersma, T. Stijnen, J.C.H Schuurbiers, R. Krams, B Lachmann, and P. D Verdouw Cardiac depression after experimental air embolism in pigs: role of addition of a surface-active agent Cardiovasc Res, June 1, 1997; 34(3): 473 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. DAVIS, A. H. JOBE, D. HÄFNER, and M. IKEGAMI Lung Function in Premature Lambs and Rabbits Treated with a Recombinant SP-C Surfactant Am. J. Respir. Crit. Care Med., February 1, 1997; 157(2): 553 - 559. [Abstract] [Full Text] |
||||
![]() |
D. DREYFUSS and G. SAUMON Ventilator-induced Lung Injury . Lessons from Experimental Studies Am. J. Respir. Crit. Care Med., January 1, 1997; 157(1): 294 - 323. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |